Wacker Chemie Ag · XETR:WCH
Wacker Chemie — Non-Deal Roadshow (December 2025)
50 slides from Wacker Chemie's roadshow presentation, December 2025
Slide 1: Growth, Cash, Costs
Growth, Cash, Costs Wacker Chemie AG December 2025
Slide 2: Disclaimer
Disclaimer • The information contained in this presentation is for background purposes only and is subject to amendment, revision and updating. Certain statements and information contained in this presentation may relate to future expectations and other forward-looking statements that are based on m
Slide 3: WACKER Is A Global Specialty Chemical Company
WACKER Is A Global Specialty Chemical Company With 27 Production Sites In All Major Regions Facts & figures €5.7bn €744m Sales EBITDA 13.0% 5.0% EBITDA % ROCE 27 21 Production Technical Sites Centers 4 16,637 Segments Employees Wacker Chemie AG, Roadshow Presentation, December 2025 3
Slide 4: Our high-tech silicones are allrounders
Our high-tech silicones are allrounders Wacker Chemie AG, Roadshow Presentation, December 2025 4
Slide 5: Our polymers improve the performance of binders
Our polymers improve the performance of binders Wacker Chemie AG, Roadshow Presentation, December 2025 5
Slide 6: We produce the medicines of tomorrow
We produce the medicines of tomorrow Wacker Chemie AG, Roadshow Presentation, December 2025 6
Slide 7: Our hyperpure polysilicon is found in half of all computer chips
Our hyperpure polysilicon is found in half of all computer chips worldwide Wacker Chemie AG, Roadshow Presentation, December 2025 7
Slide 8: WACKER Has Leading Market Positions In All Segments
WACKER Has Leading Market Positions In All Segments With €5.7 Billion In Sales In 2024 Sales by Segment Polysilicon No. 1 in semi Silicones No. 2 FY24 Sales Polymers €5.7bn No. 1 Biosolutions Leading in niches Others Wacker Chemie AG, Roadshow Presentation, December 2025 8
Slide 9: Serving Well Diversified End Markets With Specialty Products
Serving Well Diversified End Markets With Specialty Products Sales by end market Others Adhesives Smart Construction Transportation FY24 Textiles Sales €5.7bn Chemical Industries Renewable Energies Healthcare & Wellbeing Energy & Electronics Wacker Chemie AG, Roadshow Presentation, December 2025 9
Slide 10: Well Balanced Sales In All Regions
Well Balanced Sales In All Regions With Over 60% of Sales Generated Outside of Europe Sales per region for the group and per segment Asia (37%) Silicones €2.1bn Europe (39%) €2.2bn Biosolutions 100% FY24 Sales €5.7bn Polymers Rest of world (5%) Polysilicon Americas (19%) €0.3bn €1.1bn Wacker Chemie
Slide 11: Consistent Chemicals Growth In Silicones And Polymers With Polysilicon On Top
Consistent Chemicals Growth In Silicones And Polymers With Polysilicon On Top Development of salescals growth with POLYSILICON on top 10.0 Sales drivers Chemicals – specialties growth 8.0 +3% with expansion of global presence, CAGR close to customers 6.0 Biosolutions – BioPharma & BioIngredients
Slide 12: Strong EBITDA Growth Trend Till 2022 Held Back By Weak Markets Since 2023
Strong EBITDA Growth Trend Till 2022 Held Back By Weak Markets Since 2023 Development of EBITDA and ROCEh with POLYSILICON on top 2.0 40 1.5 30 1.0 20 0.5 10 € Bn 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2015-19 2020-24 Polysilicon Biosolutions Chemicals Chemicals ROCE % Wacker Chemie AG, R
Slide 13: Shareholder Returns Aligned With Net Income
Shareholder Returns Aligned With Net Income With ~ €1.4 Billion Paid Out Over Past 5 years Development of dividend Dividend policy 12.00 Pay out ~50% of net income attributable to shareholders 8.00 4.50 2.50 3.00 2.50 2.00 2.00 2.00 0.50 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 40% 56% 52
Slide 14: Resilient Financials With €4.8 Billion In Equity
Resilient Financials With €4.8 Billion In Equity & Low Financial Debt Development of financials 6 28% 51% 3 23% 21% 2 1.0x 0.9x 5 4 2 3 1 2 1 1 €Bn €Bn €Bn 2014 2024 2014 2024 2014 2024 Shareholder equity Financial liabilites Net debt % Balance sheet % Balance sheet x Net Debt / EBITDA Wacker Chemie
Slide 15: Clear Progress Towards 2030 ESG Targets And Net Zero By 2045
Clear Progress Towards 2030 ESG Targets And Net Zero By 2045 Select ESG targets -30% +13% +47% -100% 100% 100% 100 100 94% 100 83% 84% 75 -70% 75 75 57% -50% 50 50 50 25 25 25 0 0 0 2020 2024 2030 2020 2024 2030 2020 2024 2030 Cut CO2 emissions1 by 50% 100% sustainable products 100% sustainable supp
Slide 16: Strategic Focus On Growth, Cash & Cost
Strategic Focus On Growth, Cash & Cost Focus areas Expansion of Sustainability as a Focus on Continuing to Forging ahead with specialty business business model semiconductor- advance our biotech digitalization and grade polysilicon business automation Wacker Chemie AG, Roadshow Presentation, Decembe
Slide 17: Segments
Segments 1. Silicones 2. Polymers 3. Biosolutions 4. Polysilicon Wacker Chemie AG, Roadshow Presentation, December 2025 17
Slide 18: Silicones At a Glance
Silicones At a Glance Strategy & financial performance 20% 17% 14% €478m €435m €294m Fully integrated specialty Specialties for sustainable supplier solutions Full portfolio of silicones from High performance solutions for upstream, to intermediates & specialty smart construction, e-mobility, en
Slide 19: Silicones A Basis For Unlimited Applications
Silicones A Basis For Unlimited Applications Broad spectrum of adjustable properties with excellent performance attributes UV stability Long-term elasticity Surface tension Hydro- Hydro- philic phobic Softening Lubrication Water repellent Adhes- Release ive Chemical Microbial Water-vapor Con- Insula
Slide 20: Silicones Broad Market Penetration & Serving A Wide Customer Base
Silicones Broad Market Penetration & Serving A Wide Customer Base Diversified end markets Smart Construction Others Global Medical & Healthcare silicones Electronics market Electrical products Transportation Personal care Chemicals & Plastics Wacker Chemie AG, Roadshow Presentation, December 2025 20
Slide 21: Polymers At a Glance
Polymers At a Glance Strategy & financial performance 17% 16% 12% €252m €206m VAE/DPP1 market leader with world Sustainable solutions for smart €124m class tandems construction Addressing individual market Lead transformation to higher requirements with customized service construction standards
Slide 22: Polymers Performance Enablers and Binding Power
Polymers Performance Enablers and Binding Power Sales by end market Adhesives & Sealants Floor systems er CoC Paper Packaging mm er non ssuu sstr Coatings & Paints ruucc Tiles Flooring CCoonn tiotn Wall systems ion Application Paints Primers Split Nonwovens ETICS1 Skim coat Others Textiles Carpet Re
Slide 23: Biosolutions At a Glance
Biosolutions At a Glance Strategy & financial performance 16% 9% 7% €375m €271m Fast growing biotechnology Pull from advanced medicine and €197m business clean food trend Leading microbial manufacturing CDMO outsourcing trend with high technologies potential CDMO for advanced medicines Consu
Slide 24: Biosolutions Leveraging Biotechnologies For Growth
Biosolutions Leveraging Biotechnologies For Growth Sales split and market Market drivers Biopharma Life science chemicals High growth potential GMP contract CDMO outsourcing Food-grade manufacturing of Advanced medicines polyvinyl acetate biologics, vaccines, mRNA/pDNA for gum base live micr
Slide 25: Polysilicon At a Glance
Polysilicon At a Glance Strategy & financial performance 23% 29% 11% €400m Extend #1 leadership position in Capture opportunities €222m high-end Semi in PV solar Quality & process stability critical for Leverage regional differentiation & €76m high performance chips best-in-class sustainability
Slide 26: Polysilicon Extend #1 Position In Semi
Polysilicon Extend #1 Position In Semi Etching line investment in Burghausen drives CapEx in Semi Semi-market characteristics Strong Semi Growth Targeted CapEx for semi Attractive business with stable pricing and growing volumes €150m Concentrated supplier base for advanced design rules €130m +1
Slide 27: 3Q 2025 Results
3Q 2025 Results Wacker Chemie AG, Roadshow Presentation, December 2025 27
Slide 28: Q3 2025 Performance in Line With Market Expectations
Q3 2025 Performance in Line With Market Expectations Overview Financials Operations Sustainability Sales & EBITDA held back by weak Utilization rates remain unsatisfactory due to WACKER & Chem-X Initiative markets; cash flow supported by targeted ongoing macroeconomic & geopolitical actions to reduc
Slide 29: Q3 2025 EBITDA at €112m
Q3 2025 EBITDA at €112m Profit & loss Q3 2025 Q3 2024 Q3 comments Sales 1,340 1,430 • Sales -6% yoy Price -3%, FX -3%, Volume/Mix -1% Gross profit 154 213 • EBITDA -23% yoy Gross profit % 11.5% 14.9% • Performance held back by price, FX, volume/mix and unsatisfactory utilization rates EBITDA 112 145
Slide 30: Financials with €4.42bn in Equity and €781m in Liquidity
Financials with €4.42bn in Equity and €781m in Liquidity Balance sheet Assets Balance sheet per 09/30/25 Liabilities €9.4bn €8.6bn €9.4bn €8.6bn Cash & securities: • High level of liquidity at €781m 52% 54% 51% 52% Inventories: • - €173m lower YTD 11% 11% Pension provisions: 19% 19% 21% 23% • - €85m
Slide 31: Silicones: Weak Order Intake Continues in Q3
Silicones: Weak Order Intake Continues in Q3 Quarterly figures Sales (€m) Q3 Comments -7% • Volumes flat, mix weaker 727 650 745 713 673 • Sales & EBITDA held back by FX, price and mix • Q2 supported by insurance benefit Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 EBITDA (€m) / margin FY 2025 Outlook (U
Slide 32: Polymers: EBITDA at PY Level
Polymers: EBITDA at PY Level Quarterly figures Sales (€m) Q3 Comments -6% • Sales held back by FX and price as well as lower volumes 365 360 363 344 in consumer-related dispersions yoy 337 • Construction remains soft Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 EBITDA (€m) / margin FY 2025 Outlook (Updat
Slide 33: Biosolutions: Focus on Filling Capacities
Biosolutions: Focus on Filling Capacities Quarterly figures Sales (€m) Q3 Comments -7% • Sales and EBITDA driven by timing of customer project 100 106 recognition 91 87 93 • Q3 marked by soft demand environment Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 EBITDA (€m) / margin FY 2025 Outlook (Update) 16
Slide 34: Polysilicon: Strong Semi Demand, Uncertainty in Solar
Polysilicon: Strong Semi Demand, Uncertainty in Solar Quarterly figures Sales (€m) Q3 Comments -6% • Strong semi demand, volumes sold significantly higher yoy 209 209 245 218 197 • New semi etching line on schedule • Low solar-grade demand, ASP lower qoq Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 EBITD
Slide 35: Net Debt Increased to €1.16 Billion
Net Debt Increased to €1.16 Billion Year-to-date development of net debt 128 -691 -411 -124 -31 -27 -1,156 Net financial Cash flow from Cash flow from Dividend paid, Lease liabilities Fx, others Net financial debt debt 12.31.2024 operating activities investing before WACKER 09.30.2025 securities Wac
Slide 36: Cost Project Launched in October 2025
Cost Project Launched in October 2025 With Targeted Savings Of Over €300 Million Per Year Cost project details Comprehensive cost project started • Aim to achieve significant cost savings primarily in our fixed production setup • Targeted savings of over 300 million euros per year • Half of the savi
Slide 37: FY 2025 Guidance Refined With The Presentation Of Q3 2025 Results
FY 2025 Guidance Refined With The Presentation Of Q3 2025 Results Group Guidance In €m FY 2024 Outlook 2025 Sales 5,722 At the lower end of the €5.5 to 5.9bn range EBITDA1 744 In the lower half of the €500 to 700m range EBITDA margin (%)1 13.0 Substantially lower than prior year Net cash flow -326 N
Slide 38: Financials
Financials Wacker Chemie AG, Roadshow Presentation, December 2025 38
Slide 39: Solid Capital Structure To Support Growth & Maintain Resilience
Financials Solid Capital Structure To Support Growth & Maintain Resilience Capital allocation priorities Growth: Dividends Financials: Diversified portfolio of ~ 50% of net income from Strong balance sheet with downstream projects continuing operations solid capital structure focused on profit
Slide 40: Financials Q3 Results
Financials Q3 Results Year-over-year performance In €m Q3 2025 Q3 20241 % Sales 1,340 1,430 -6% EBITDA reported 112 145 -23% EBITDA-Margin 8.3% 10.2% - EBIT -20 30 - EBIT-Margin -1.5% 2.1% - Net income for the period -82 34 - EPS -1.73 0.56 - CapEx 111 149 -26% Net Cashflow 19 -99 - Net Financial de
Slide 41: Financials Recent Segment Performance
Financials Recent Segment Performance 9M and Q3 results for the group and by segment In €m 9M 2025 9M 20241 Q3 2025 Q3 20241 Sales EBITDA % Sales EBITDA % Sales EBITDA % Sales EBITDA % Chemicals 3,199 418 13.1 3,282 432 13.2 1,017 134 13.1 1,092 152 13.9 SILICONES 2,132 294 13.8 2,156 272 12.6 673 8
Slide 42: Financials Historic Group Key Figures
Financials Historic Group Key Figures In €m 20241 20231 2022 2021 2020 Sales 5.722 6,402 8,209 6,208 4,692 EBITDA 744 773 2,081 1,539 666 EBITDA margin 13.0% 12.1% 25.4% 24.8% 14.2% EBIT 271 354 1,679 1,134 263 EBIT margin 4.7% 5.5% 20.4% 18.3% 5.6% Net income for the period 261 327 1,282 828 202 Ne
Slide 43: Financials Historic Segment Performance
Financials Historic Segment Performance In €m 20241 20231 2022 2021 2020 Sales EBITDA % Sales EBITDA % Sales EBITDA % Sales EBITDA % Sales EBITDA % Chemicals 4,269 535 12.5 4,321 486 11.2 5,449 1,165 21.4 4,273 806 18.9 3,789 696 18.6 SILICONES 2,805 341 12.2 2,741 233 8.5 3,453 876 25.4 2,599 553 2
Slide 44: Financials ROCE
Financials ROCE In €m 2024 2023 2022 2021 2020 EBIT Chemicals 339 305 991 620 506 Biosolutions -17 -20 -5 21 22 Polysilicon 70 203 705 529 -148 Group 290 405 1,571 1,134 263 Capital Employed €M Chemicals 3,037 3,121 2,817 2,149 2,183 Biosolutions 716 524 340 243 201 Polysilicon 956 871 947 967 1,199
Slide 45: ESG
ESG Wacker Chemie AG, Roadshow Presentation, December 2025 45
Slide 46: WACKER With Top Environment, Social And Governance ESG Ratings
WACKER With Top Environment, Social And Governance ESG Ratings Best practice management of climate related risks & opportunities CDP: ISS ESG: MSCI: Ecovadis: Sustainalytics: 2024 Climate Prime, Rating B- BB rating Top 5% of all “Management of Change: A Score companies rated material ESG issues Wate
Slide 47: Enabling Customers To Reduce CO2 Emissions, Save Resources, And Improve Efficiency
Enabling Customers To Reduce CO2 Emissions, Save Resources, And Improve Efficiency WACKER CO2 abatement technologies addressing sectors responsible for majority of global emissions Buildings Transport Energy Industry >2/3 of WACKER sales address resource Durable facade coatings Highly resistant powe
Slide 48: Pathway To Net Zero While Capitalizing On Growth Opportunities
Pathway To Net Zero While Capitalizing On Growth Opportunities Growth with lower absolute emissions (m t CO2e) Pathway to Net Zero by 2045 Footprint Down -50% Net Benchmark operations with Zero integrated production processes 3.6 Scope 2 Science Based Target1: -50% Reduction in absolute GHG emissi
Slide 49: Progress Towards 2030 Sustainability Targets
Progress Towards 2030 Sustainability Targets Three focus areas Value up Footprint down Collaboration around Products meet sustainability criteria Reduction in absolute GHG emissions Reduction in absolute upstream GHG emissions 89% 90% 94% 94% 100% 3.6 3.7 5.2 83% 3.2 4.5 4.2 2.8 2.5 3.7 3.9 3.3 1.8
Slide 50: WACKER: Issuer, Contact and Additional Information
WACKER: Issuer, Contact and Additional Information Investor relations contacts Financial Calendar March 11, 2026 FY 2025 Results Joerg Hoffmann, CFA April 29, 2026 Q1 2026 Results Tel. +49 89 6279 1633 | joerg.hoffmann@wacker.com May 6, 2026 AGM Scott McCollister July 30, 2026 Q2 2026 Results Tel. +